Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju
Authors:ID Oblak, Irena (Author)
Files:.pdf PDF - Presentation file, download (311,87 KB)
MD5: 857CBB0A41BC0C1D449951CC8BE0DEC4
PID: 20.500.12556/dirros/cf8ffc74-a39a-4c8a-9325-4670a769c97a
 
Language:Slovenian
Typology:1.08 - Published Scientific Conference Contribution
Organization:Logo OI - Institute of Oncology
Keywords:bolniki, rak debelega črevesa, rak danke, rak prebavil
Publication status:Published
Publication version:Version of Record
Year of publishing:2013
Number of pages:str. 37-38, 76
Numbering:Letn. 17, št. 1
PID:20.500.12556/DiRROS-9030 New window
UDC:616.3-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-MMKGNA7W
COBISS.SI-ID:1554811 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:2566
Downloads:628
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Šola tumorjev prebavil, Ljubljana, 30. 11. 2012
Publisher:Onkološki inštitut
COBISS.SI-ID:1553275 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:Follow-up of colorectal cancer patients after radical treatment
Abstract:After completed treatment, either surgical or combined treatment of colorectal carcinoma, it is necessary to follow up patients regularly and in accordance with the recommended protocol. The purpose of such follow-up is to detect the disease or its recurrence as early as possible, including pre-cancerous lesions or potential metachronous (newly developed) tumours which can be treated successfully at an early stage. Follow-up is important also for the treatment of late complications, it enables psychological support to the patients, and finally, we can also track and assess our own performance. It is known that colorectal cancer recurs in 30 do 50% of patients. As many as 70% of recurrences are detected within the first two years, 80% in the first three years, and 90% or more disease recurrences are found within five years after surgery of the primary tumour. It has been shown that regular follow-up of patients after their treatment improves the outcome of their disease and reduces mortality in patients by 9% to 13%. We must adapt it to each patient separately, taking into account both his age and general condition, stage of the disease, concurrent diseases, and further treatment possibilities in the event of a recurrence.


Archive

niGradiv

Back